Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  glutaminase inhibitor CB-839
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CX-839-001, NCI-2014-01059, NCT02071862
Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CX-839-002, NCI-2014-02615, NCT02071888
Study of the Glutaminase Inhibitor CB-839 in Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CX-839-003, NCI-2014-00589, NCT02071927
Start Over